PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) General Information

Description

A hedgehog signaling pathway blocker intended for the treatment of Gorlin syndrome.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • San Francisco, CA
  • United States
Primary Industry
Buildings and Property
Corporate Office
  • San Francisco, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco)‘s full profile, request access.

Request a free trial

PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco)‘s full profile, request access.

Request a free trial

PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) FAQs

  • Where is PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) headquartered?

    PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) is headquartered in San Francisco, CA.

  • What industry is PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) in?

    PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco)’s primary industry is Buildings and Property.

  • Is PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) a private or public company?

    PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) is a Private company.

  • What is the current valuation of PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco)?

    The current valuation of PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) is .

  • What is PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco)’s current revenue?

    The current revenue for PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) is .

  • Who are PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco)’s investors?

    PellePharm has invested in PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco).

  • When was PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) acquired?

    PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) was acquired on 30-Jan-2023.

  • Who acquired PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco)?

    PellePharm (Hedgehog Signaling Pathway Blocker in San Francisco) was acquired by Sol-Gel Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process